IndiaFilingsIndiaFilings
India FlagRegister India Company
UAE FlagRegister UAE Company
USA FlagRegister USA Company

DRUG GENIE LLP

LLPIN : ACX-1796|ROC: RoC-HyderabadActive
Last Updated On : 20-04-2026
LLPINACX-1796
LLP NameDRUG GENIE LLP
Number of Partners2
Number of Designated Partners2
ROC CodeRoC-Hyderabad
Date of Incorporation15-04-2026
Registered AddressF. No.402,Spectrum Elite Jana Chaitanya Colony Ibrahim Bagh Lines Hyderabad Golconda Telangana India 500031
Email ID*****ar.marri@gmail.com
Total Obligation of Contribution1,00,000
Main division of business activity to be carried out in India47
Description of main divisionRETAILSALEOFPHARMACEUTICALS,MEDICALANDORTHOPAEDICGOODSANDTOILETARTICLES
LLP StatusActive

Directors / Signatory Details

DIN / PANNameBegin Date
11663249LANKA UMA SRIDEVI
08476494BHASKARAIAH MARRI
DRUG GENIE LLP is a Limited Liability Partnership (LLP) governed by the LLP Act, 2008. Registered under the Registrar of Companies RoC-Hyderabad, it operates as a non-government entity. According to the Ministry of Corporate Affairs (MCA), this LLP was incorporated on 15-04-2026 and last updated on 20-04-2026. Its LLP Identification Number (LLPIN) is , and the registration number is . Currently, its eFiling status is listed as “Active” as per MCA records.
From a financial standpoint, DRUG GENIE LLP has a total contribution of INR 1,00,000. Details of the latest financial filings, such as the Statement of Accounts and Solvency or Annual Returns, are unavailable, indicating limited publicly disclosed financial data.
The registered office address is F. No.402,Spectrum Elite Jana Chaitanya Colony Ibrahim Bagh Lines Hyderabad Golconda Telangana India 500031. Correspondence or inquiries may be sent to the official email address, *****ar.marri@gmail.com.
For those interested in further details, below are some frequently asked questions:
Disclaimer

IndiaFilings is not affiliated with any companies listed on this website and does not represent them. Please contact the respective company directly for their inquiries.